Priority 6 from the Idiopathic Intracranial Hypertension PSP
| UNCERTAINTY: Can IIH biomarkers (tests in body fluids for example urine, saliva, blood, or brain scans) help diagnosis, predict the risk and guide therapy decisions in IIH? (JLA PSP Priority 6) | |
|---|---|
| Overall ranking | 6 |
| JLA question ID | 0066/6 |
| Explanatory note | Not available for this PSP |
| Evidence |
None identified |
| Health Research Classification System category | Neurological |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | What are the prognostic markers for IIH? ~ How closely is weight correlated with risk of IIH (relapse) compared with other factors? ~ Are there any molecular mechanisms that can serve as potential targets for the development of novel therapies? ~ Why is it difficult to get a diagnosis of IIH? |
| Submitted by | See data spreadsheet on JLA website |
| PSP information | |
|---|---|
| PSP unique ID | 0066 |
| PSP name | Idiopathic Intracranial Hypertension |
| Total number of uncertainties identified by this PSP. | 48 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 27 April 2018 |